Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease

C Steenholdt; C Enevold; M A Ainsworth; J Brynskov; O Ø Thomsen; K Bendtzen

doi:10.1111/apt.12010

Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease

C Steenholdt
, C Enevold
, M A Ainsworth
, J Brynskov
, O Ø Thomsen
, K Bendtzen

49 Citationer (Scopus)

Abstract

Single nucleotide polymorphisms (SNPs) in TNF receptor superfamily (TNFRSF) 1A and 1B, and Fas ligand (FASLG) genes, have been associated with responsiveness to infliximab (IFX) in Crohn's disease.

Originalsprog	Engelsk
Tidsskrift	Alimentary Pharmacology and Therapeutics
Vol/bind	36
Udgave nummer	7
Sider (fra-til)	650-9
Antal sider	10
ISSN	0269-2813
DOI	https://doi.org/10.1111/apt.12010
Status	Udgivet - 2012

Adgang til dokumentet

10.1111/apt.12010

Citationsformater

Steenholdt, C., Enevold, C., Ainsworth, M. A., Brynskov, J., Thomsen, O. Ø., & Bendtzen, K. (2012). Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease. Alimentary Pharmacology and Therapeutics, 36(7), 650-9. https://doi.org/10.1111/apt.12010

Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease. / Steenholdt, C; Enevold, C; Ainsworth, M A et al.
I: Alimentary Pharmacology and Therapeutics, Bind 36, Nr. 7, 2012, s. 650-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Steenholdt, C, Enevold, C, Ainsworth, MA, Brynskov, J, Thomsen, OØ & Bendtzen, K 2012, 'Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease', Alimentary Pharmacology and Therapeutics, bind 36, nr. 7, s. 650-9. https://doi.org/10.1111/apt.12010

@article{0e1504499faa44ffbf1e57e7ccbbf643,

title = "Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease",

abstract = "Single nucleotide polymorphisms (SNPs) in TNF receptor superfamily (TNFRSF) 1A and 1B, and Fas ligand (FASLG) genes, have been associated with responsiveness to infliximab (IFX) in Crohn's disease.",

author = "C Steenholdt and C Enevold and Ainsworth, \{M A\} and J Brynskov and Thomsen, \{O {\O}\} and K Bendtzen",

note = "{\textcopyright} 2012 Blackwell Publishing Ltd.",

year = "2012",

doi = "10.1111/apt.12010",

language = "English",

volume = "36",

pages = "650--9",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease

AU - Steenholdt, C

AU - Enevold, C

AU - Ainsworth, M A

AU - Brynskov, J

AU - Thomsen, O Ø

AU - Bendtzen, K

PY - 2012

Y1 - 2012

N2 - Single nucleotide polymorphisms (SNPs) in TNF receptor superfamily (TNFRSF) 1A and 1B, and Fas ligand (FASLG) genes, have been associated with responsiveness to infliximab (IFX) in Crohn's disease.

AB - Single nucleotide polymorphisms (SNPs) in TNF receptor superfamily (TNFRSF) 1A and 1B, and Fas ligand (FASLG) genes, have been associated with responsiveness to infliximab (IFX) in Crohn's disease.

U2 - 10.1111/apt.12010

DO - 10.1111/apt.12010

M3 - Journal article

C2 - 22860894

SN - 0269-2813

VL - 36

SP - 650

EP - 659

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 7

ER -

Genetic polymorphisms of tumour necrosis factor receptor superfamily 1b and fas ligand are associated with clinical efficacy and/or acute severe infusion reactions to infliximab in Crohn's disease

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater